Tingting Feng Selected Research

Neoplasm Metastasis (Metastasis)

9/2023	Reciprocal negative feedback regulation of ATF6α and PTEN promotes prostate cancer progression.
2/2023	From degenerative disease to malignant tumors: Insight to the function of ApoE.
1/2022	ATF6α promotes prostate cancer progression by enhancing PLA2G4A-mediated arachidonic acid metabolism and protecting tumor cells against ferroptosis.
7/2019	Cyclin A1 is associated with poor prognosis in oesophageal squamous cell carcinoma.
9/2018	Polyphyllin I inhibits invasion and epithelial-mesenchymal transition via CIP2A/PP2A/ERK signaling in prostate cancer.
1/2017	Integrin β1 is a critical effector in promoting metastasis and chemo-resistance of esophageal squamous cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tingting Feng Research Topics

Disease

40	Neoplasms (Cancer) 03/2024 - 05/2009
14	Infections 05/2024 - 07/2011
12	Prostatic Neoplasms (Prostate Cancer) 12/2023 - 11/2017
10	Hepatocellular Carcinoma (Hepatoma) 11/2023 - 12/2014
9	Virus Diseases (Viral Diseases) 03/2024 - 01/2014
8	Atherosclerosis 04/2023 - 11/2011
7	Inflammation (Inflammations) 02/2023 - 01/2019
6	Neoplasm Metastasis (Metastasis) 09/2023 - 01/2017
4	Carcinogenesis 07/2023 - 08/2009
4	Bacterial Infections (Bacterial Infection) 11/2019 - 07/2011
3	Stomach Neoplasms (Stomach Cancer) 10/2023 - 09/2017
3	Adenocarcinoma 04/2023 - 10/2020
3	Coronary Disease (Coronary Heart Disease) 02/2023 - 01/2020
3	Lymphatic Metastasis 07/2019 - 01/2017
2	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2024 - 02/2023
2	Diabetic Retinopathy (Retinopathy, Diabetic) 03/2024 - 01/2022
2	Breast Neoplasms (Breast Cancer) 03/2024 - 01/2019
2	Lung Injury 12/2023 - 03/2016
2	Abdominal Aortic Aneurysm 10/2023 - 01/2016
2	Pancreatic Neoplasms (Pancreatic Cancer) 08/2023 - 01/2023
2	COVID-19 02/2023 - 01/2021
2	Non-alcoholic Fatty Liver Disease 11/2022 - 01/2022
2	Cognitive Dysfunction 11/2022 - 01/2021
2	Vesicular Stomatitis 10/2022 - 10/2015
2	Communicable Diseases (Infectious Diseases) 06/2022 - 11/2019
2	Insulin Resistance 01/2022 - 01/2018
2	Wounds and Injuries (Trauma) 11/2021 - 03/2012
2	Hypertension (High Blood Pressure) 11/2021 - 11/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2021 - 11/2019
2	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 09/2016
2	Synovitis 01/2020 - 01/2019
2	Arthritis (Polyarthritis) 01/2020 - 01/2019
2	Esophageal Squamous Cell Carcinoma 07/2019 - 01/2017
2	RNA Virus Infections 01/2018 - 01/2017
2	Leukemia 11/2017 - 08/2009
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2016 - 08/2014
1	Pathologic Processes 04/2024
1	Parkinson Disease (Parkinson's Disease) 03/2024
1	Wilms Tumor (Wilm's Tumor) 01/2024

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2015
6	Biomarkers (Surrogate Marker)IBA 03/2024 - 03/2020
6	Antiviral Agents (Antivirals)IBA 10/2022 - 11/2012
6	Metformin (Glucophage)FDA LinkGeneric 05/2022 - 06/2014
6	AndrogensIBA 04/2022 - 11/2017
6	CholesterolIBA 01/2018 - 11/2011
5	InterferonsIBA 03/2024 - 01/2015
5	Small Interfering RNA (siRNA)IBA 03/2021 - 08/2009
5	ProgranulinsIBA 09/2016 - 08/2014
4	CytokinesIBA 12/2023 - 11/2012
4	Apolipoproteins E (ApoE)IBA 02/2023 - 08/2014
4	Peptides (Polypeptides)IBA 01/2023 - 04/2022
4	enzalutamideIBA 04/2022 - 11/2017
4	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 11/2017
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 04/2015
3	RNA (Ribonucleic Acid)IBA 11/2023 - 08/2009
3	Messenger RNA (mRNA)IBA 10/2023 - 12/2017
3	LipidsIBA 04/2023 - 11/2011
3	Nucleic AcidsIBA 02/2023 - 01/2017
3	Viral ProteinsIBA 12/2022 - 01/2018
3	Transcription Factors (Transcription Factor)IBA 01/2022 - 11/2012
3	Triglycerides (Triacylglycerol)IBA 01/2022 - 01/2018
3	UbiquitinIBA 10/2021 - 01/2018
3	Interferon Type IIBA 01/2021 - 01/2017
3	Sirolimus (Rapamycin)FDA Link 02/2020 - 01/2016
2	Mechanistic Target of Rapamycin Complex 1IBA 11/2023 - 01/2017
2	Histones (Histone)IBA 10/2023 - 11/2017
2	Protein Isoforms (Isoforms)IBA 02/2023 - 10/2020
2	Eosine Yellowish-(YS) (Eosin)IBA 02/2023 - 03/2016
2	Therapeutic UsesIBA 01/2023 - 01/2020
2	PDZ-binding kinaseIBA 01/2023 - 01/2021
2	Matrix Metalloproteinases (MMPs)IBA 10/2022 - 01/2014
2	AntibodiesIBA 01/2022 - 01/2019
2	Proteasome Endopeptidase Complex (Proteasome)IBA 10/2021 - 11/2017
2	Phosphotransferases (Kinase)IBA 10/2021 - 01/2021
2	Sorafenib (BAY 43-9006)FDA Link 03/2021 - 01/2017
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2021
2	EndotoxinsIBA 01/2021 - 09/2016
2	Ubiquitin-Specific ProteasesIBA 01/2021 - 01/2020
2	Collagen Type II (Type II Collagen)IBA 01/2020 - 01/2019
2	Cullin Proteins (Cullins)IBA 03/2019 - 01/2019
2	EnzymesIBA 09/2018 - 03/2016
2	Sirtuin 1IBA 01/2018 - 01/2018
2	IntegrinsIBA 01/2017 - 05/2009
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016 - 08/2014
2	Liver X ReceptorsIBA 12/2014 - 04/2014
2	rutecarpineIBA 08/2014 - 08/2014
1	Cadherins (E-Cadherin)IBA 05/2024
1	Peroxynitrous Acid (Peroxynitrite)IBA 04/2024
1	Superoxides (Superoxide)IBA 04/2024
1	Oxidants (Oxidizing Agents)IBA 04/2024
1	Dichlorodiphenyl Dichloroethylene (DDE)IBA 03/2024
1	HLA-DR Antigens (HLA-DR)IBA 03/2024
1	taxaneIBA 03/2024
1	6-methyladenineIBA 01/2024
1	HomocysteineIBA 12/2023

Therapy/Procedure

9	Therapeutics 03/2024 - 11/2014
6	Castration 04/2022 - 11/2017
3	Drug Therapy (Chemotherapy) 03/2019 - 11/2017
2	Phage Therapy 01/2021 - 11/2019
1	Neoadjuvant Therapy 03/2024